NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
官方登记数据
0位关注者
1992成立于
关于 NEUROCRINE BIOSCIENCES INC
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
成立1992
法律形式C Corporation
状态营业中
专利52 项专利
SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL…JP2025157396A · 2025
METHODS FOR ADMINISTRATION OF CERTAIN VMAT2 INHIBITORSJP2025146959A · 2025
关键数据
法律信息
| 法定名称 | NEUROCRINE BIOSCIENCES INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 914475在 SEC EDGAR 上查看 ↗ |
| EIN | 33-0525145 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面